Et pilotstudie af effekten af transdermalt magnesium
This study was designed to test whether transdermal application of a 31% magnesium chloride formulation could alter serum magnesium levels and whole body calcium/magnesium ratios. Patients were screened using a sophisticated hair analysis to determine pre-treatment levels of cellular magnesium and then again following the adopted protocol for product application.
After 12 weeks’ treatment 89% of subjects raised their cellular magnesium levels with an average increase of 59.7% recorded. Equivalent results using oral supplementation have been reported over 9-24 months. Furthermore all patients showed an improvement in the calcium/magnesium balance ratio where the mean improvement seen over the trial period was 25.2%.